BRUCELVAC B-19

Pharmaceutical form:

Lyophilisate for preparation of an injectable suspension.

Indications:

Brucelvac-B19 is intended for the prevention of brucellosis

in cattle and young cattle after authorization of

veterinary services on affected farms in terms of

of brucellosis and in farms free of brucellosis in the event of

infectious risk of animals.

Administration:

Subcutaneous route at the posterior third of the neck.

Vaccination dose: 4 ml.